Healthcare provider profile · identity verified

Gary D. Sugimoto, MD

Family Practice · FONTANA, CA · NPI 1215004114

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	598	72
Atorvastatin Calcium	Atorvastatin Calcium	432	157
Amlodipine Besylate	Amlodipine Besylate	375	126
Levothyroxine Sodium	Levothyroxine Sodium	289	95
Losartan Potassium	Losartan Potassium	267	99
Atenolol	Atenolol	242	76
Lisinopril	Lisinopril	221	75
Omeprazole	Omeprazole	200	76
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	190	24
Tamsulosin Hcl	Tamsulosin Hcl	172	58
Albuterol Sulfate Hfa	Albuterol Sulfate	156	65
Metformin Hcl	Metformin Hcl	153	58
Lovastatin	Lovastatin	144	46
Pantoprazole Sodium	Pantoprazole Sodium	141	51
Gabapentin	Gabapentin	139	40
Glipizide	Glipizide	134	53
Simvastatin	Simvastatin	124	42
Trazodone Hcl	Trazodone Hcl	120	31
Metformin Hcl Er	Metformin Hcl	119	45
Alendronate Sodium	Alendronate Sodium	111	33
Tramadol Hcl	Tramadol Hcl	110	23
Alprazolam	Alprazolam	105	18
Potassium Chloride	Potassium Chloride	103	40
Ibuprofen	Ibuprofen	99	37
Ozempic	Semaglutide	96	22
Meloxicam	Meloxicam	95	27
Hydrochlorothiazide	Hydrochlorothiazide	91	30
Montelukast Sodium	Montelukast Sodium	91	26
Pradaxa	Dabigatran Etexilate Mesylate	85	23
Rosuvastatin Calcium	Rosuvastatin Calcium	84	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	28
Metoprolol Tartrate	Metoprolol Tartrate	77	32
Oxycodone Hcl	Oxycodone Hcl	74	suppressed
Temazepam	Temazepam	68	suppressed
Furosemide	Furosemide	61	22
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	17
Bisoprolol Fumarate	Bisoprolol Fumarate	55	23
Lorazepam	Lorazepam	55	suppressed
Sertraline Hcl	Sertraline Hcl	55	16
Wixela Inhub	Fluticasone Propion/Salmeterol	54	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	46	20
Naproxen	Naproxen	44	13
Alvesco	Ciclesonide	42	18
Buspirone Hcl	Buspirone Hcl	41	suppressed
Famotidine	Famotidine	40	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	15
Duloxetine Hcl	Duloxetine Hcl	36	11
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Prednisone	Prednisone	33	18
Allopurinol	Allopurinol	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	11
Jardiance	Empagliflozin	32	13
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Eliquis	Apixaban	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	12
Pravastatin Sodium	Pravastatin Sodium	31	12
Pregabalin	Pregabalin	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	11
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Finasteride	Finasteride	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Humulin N	Insulin Nph Human Isophane	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Metoprolol Succinate	Metoprolol Succinate	29	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	18
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Hydrocortisone	Hydrocortisone	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Acyclovir	Acyclovir	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Naloxone Hcl	Naloxone Hcl	20	suppressed
Cephalexin	Cephalexin	19	16
Glipizide Er	Glipizide	19	suppressed
Lactulose	Lactulose	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Scopolamine	Scopolamine	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Primidone	Primidone	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Estradiol	Estradiol	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nystatin	Nystatin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Colchicine	Colchicine	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Liraglutide	Liraglutide	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error